Author: Cramer H1, Lauche R2, Haller H2, Steckhan N3, Michalsen A4, Dobos G2.
Affiliation: 1Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany. Electronic address: h.cramer@kliniken-essen-mitte.de. 2Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany. 3Immanuel Hospital Berlin, Department of Internal and Complementary Medicine, Berlin, Germany. 4Immanuel Hospital Berlin, Department of Internal and Complementary Medicine, Berlin, Germany; Charité-Universitätsmedizin Berlin, Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Germany.
Conference/Journal: Int J Cardiol.
Date published: 2014 Feb 25
Other:
Pages: S0167-5273(14)00370-2 , Special Notes: doi: 10.1016/j.ijcard.2014.02.017 , Word Count: 288
BACKGROUND:
The aim of this review was to systematically assess and meta-analyze the effects of yoga on modifiable biological cardiovascular disease risk factors in the general population and in high-risk disease groups.
METHODS:
MEDLINE/PubMed, Scopus, the Cochrane Library, and IndMED were screened through August 2013 for randomized controlled trials (RCTs) on yoga for predefined cardiovascular risk factors in healthy participants, non-diabetic participants with high risk for cardiovascular disease, or participants with type 2 diabetes mellitus. Risk of bias was assessed using the Cochrane risk of bias tool.
RESULTS:
Forty-four RCTs with a total of 3168 participants were included. Risk of bias was high or unclear for most RCTs. Relative to usual care or no intervention, yoga improved systolic (mean difference (MD)=-5.85mmHg; 95% confidence interval (CI)=-8.81, -2.89) and diastolic blood pressure (MD=-4.12mmHg; 95%CI=-6.55, -1.69), heart rate (MD=-6.59bpm; 95%CI=-12.89, -0.28), respiratory rate (MD=-0.93breaths/min; 95%CI=-1.70, -0.15), waist circumference (MD=-1.95cm; 95%CI=-3.01, -0.89), waist/hip ratio (MD=-0.02; 95%CI=-0.03, -0.00), total cholesterol (MD=-13.09mg/dl; 95%CI=-19.60, -6.59), HDL (MD=2.94mg/dl; 95%CI=0.57, 5.31), VLDL (MD=-5.70mg/dl; 95%CI=-7.36, -4.03), triglycerides (MD=-20.97mg/dl; 95%CI=-28.61, -13.32), HbA1c (MD=-0.45%; 95%CI=-0.87, -0.02), and insulin resistance (MD=-0.19; 95%CI=-0.30, -0.08). Relative to exercise, yoga improved HDL (MD=3.70mg/dl; 95%CI=1.14, 6.26).
CONCLUSIONS:
This meta-analysis revealed evidence for clinically important effects of yoga on most biological cardiovascular disease risk factors. Despite methodological drawbacks of the included studies, yoga can be considered as an ancillary intervention for the general population and for patients with increased risk of cardiovascular disease.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
KEYWORDS:
Cardiovascular diseases, Hypertension, Meta-analysis, Metabolic syndrome, Type 2 diabetes, Yoga
PMID: 24636547